These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. How do psychedelics work? Carhart-Harris RL Curr Opin Psychiatry; 2019 Jan; 32(1):16-21. PubMed ID: 30394903 [TBL] [Abstract][Full Text] [Related]
3. What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish throughout our lives, as well as to enhance our dying. Mackenzie R Curr Drug Abuse Rev; 2014; 7(3):136-45. PubMed ID: 25563449 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review. van Elk M; Yaden DB Neurosci Biobehav Rev; 2022 Sep; 140():104793. PubMed ID: 35878791 [TBL] [Abstract][Full Text] [Related]
5. Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of Hallucinogens. Dupuis D Front Psychol; 2021; 12():730031. PubMed ID: 34887799 [TBL] [Abstract][Full Text] [Related]
7. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Vollenweider FX; Kometer M Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121 [TBL] [Abstract][Full Text] [Related]
8. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Moreton SG; Szalla L; Menzies RE; Arena AF Psychopharmacology (Berl); 2020 Jan; 237(1):21-32. PubMed ID: 31784805 [TBL] [Abstract][Full Text] [Related]
9. Ethical Issues Regarding Nonsubjective Psychedelics as Standard of Care. Yaden DB; Earp BD; Griffiths RR Camb Q Healthc Ethics; 2022 Oct; 31(4):464-471. PubMed ID: 36398520 [TBL] [Abstract][Full Text] [Related]
10. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications. Kraehenmann R Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125 [TBL] [Abstract][Full Text] [Related]
12. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Dourron HM; Strauss C; Hendricks PS Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878 [TBL] [Abstract][Full Text] [Related]
13. Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture. Hartogsohn I Transcult Psychiatry; 2022 Oct; 59(5):579-591. PubMed ID: 35818775 [TBL] [Abstract][Full Text] [Related]
14. An introduction to psychedelic neuroscience. Calvey T; Howells FM Prog Brain Res; 2018; 242():1-23. PubMed ID: 30471677 [TBL] [Abstract][Full Text] [Related]
15. Human behavioral pharmacology of psychedelics. Strickland JC; Johnson MW Adv Pharmacol; 2022; 93():105-132. PubMed ID: 35341564 [TBL] [Abstract][Full Text] [Related]
16. The History of Psychedelics in Psychiatry. Nichols DE; Walter H Pharmacopsychiatry; 2021 Jul; 54(4):151-166. PubMed ID: 33285579 [TBL] [Abstract][Full Text] [Related]
18. Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics. Tófoli LF; de Araujo DB Int Rev Neurobiol; 2016; 129():157-85. PubMed ID: 27503452 [TBL] [Abstract][Full Text] [Related]
19. Molecular targets of psychedelic-induced plasticity. Jaster AM; de la Fuente Revenga M; González-Maeso J J Neurochem; 2022 Jul; 162(1):80-88. PubMed ID: 34741320 [TBL] [Abstract][Full Text] [Related]
20. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Johnson MW; Hendricks PS; Barrett FS; Griffiths RR Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]